Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer

Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Taira KinoshitaToshifusa Nakajima

Abstract

We conducted a feasibility study using S-1, a novel oral derivative of 5-fluorouracil, as postoperative adjuvant chemotherapy for curatively resected gastric cancer patients. Adjuvant chemotherapy consisted of eight courses (4-week administration and 2-week withdrawal) of S-1, at 80-120 mg/body per day. Forty-one patients from 11 institutions were enrolled in this pilot study, from November 1999 to October 2000. Thirty-five patients were eligible. In 7 patients, S-1 administration was discontinued due to recurrence. Among the 28 patients without recurrence, the planned eight courses of S-1 were administered to 17 patients (60.7%). In 4 patients, S-1 administration was discontinued due to subjective symptoms, such as anorexia, in the first course. Adverse reactions such as neutropenia, leukopenia, elevated total bilirubin, anorexia, general fatigue, diarrhea, nausea, and stomatitis were seen in more than half of the patients. Although grade 3 neutropenia (29.3%), leukopenia (9.8%), and diarrhea (9.8%) were observed, no grade 4 adverse effects appeared. Compared with the treatment of unresectable or recurrent gastric cancer with S-1, the incidence of adverse reactions in the adjuvant setting was slightly higher, probably due to t...Continue Reading

Citations

Aug 11, 2007·Cancer Chemotherapy and Pharmacology·Mitsugu KochiTadatoshi Takayama
Sep 8, 2010·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Yasuhiro KoderaUNKNOWN Chubu Clinical Cancer Group
Feb 18, 2011·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Satoru IwasaYasuhiro Shimada
Nov 6, 2007·The New England Journal of Medicine·Shinichi SakuramotoUNKNOWN ACTS-GC Group
Jul 1, 2009·Annals of Surgical Oncology·Eiji OkiYoshihiko Maehara
Apr 20, 2013·World Journal of Gastroenterology : WJG·Lei ChenYu-Xin Chen
May 5, 2009·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Tokujiro YanoUNKNOWN Lung Oncology Group in Kyushu (LOGIK)
Mar 31, 2009·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·Y KoderaUNKNOWN Chubu Clinical Oncology Group
Mar 26, 2008·British Journal of Cancer·T Kubota
Sep 29, 2005·British Journal of Cancer·M TsukudaUNKNOWN Chemotherapy Study Group of Head and Neck Cancer
Jun 29, 2006·Japanese Journal of Clinical Oncology·Yuji UedaUNKNOWN Hokuriku-Kinki Immunochemo-Therapy Study Group-Gastric Cancer (HKIT-GC)
Sep 19, 2014·World Journal of Gastroenterology : WJG·Jun NakamuraKohji Miyazaki
Apr 19, 2021·World Journal of Surgical Oncology·Hung-Hsuan YenI-Rue Lai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

Related Papers

The New England Journal of Medicine
Shinichi SakuramotoACTS-GC Group
The New England Journal of Medicine
Harubumi KatoJapan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy
The New England Journal of Medicine
Timothy WintonNational Cancer Institute of the United States Intergroup JBR.10 Trial Investigators
The New England Journal of Medicine
Rodrigo ArriagadaInternational Adjuvant Lung Cancer Trial Collaborative Group
© 2022 Meta ULC. All rights reserved